Imagine a world where a vaccine designed to fight a deadly virus also holds the key to battling one of our biggest killers: cancer. That's not just science fiction—it's a startling possibility emerging from recent research. As we reflect on our readiness for future pandemics, the rapid development of Covid vaccines stands out as a triumph, saving countless lives since 2021. But here's where it gets controversial: what if these vaccines could do even more, potentially extending the lives of cancer patients by a whopping 75%? Stick around, because this discovery might just change how we approach one of humanity's greatest health challenges forever.
When people ask me if we're better equipped for the next global health crisis, my response is nuanced. On the one hand, the pandemic exposed gaps in our systems, but on the bright side, we've witnessed unprecedented scientific breakthroughs in vaccine technology. The Covid vaccines were created at lightning speed—far faster than any before them—and they're credited with preventing millions of deaths starting in 2021, as detailed in a comprehensive study published in The Lancet. Take the mRNA vaccines from Pfizer/BioNTech and Moderna, for instance; their blueprints were crafted almost immediately after the Sars-CoV-2 genome was released in January 2020. By the end of that year, after rigorous safety testing, they received approval in the UK, marking a new era in medical innovation.
But could these vaccines offer unexpected perks beyond fighting the virus? A fascinating new study in Nature suggests they might, revealing that mRNA jabs can spark a robust immune reaction that boosts the average survival time for certain cancer sufferers by around 75%. This emerging evidence, still in development, hints at the immense potential of adapting existing, thoroughly vetted vaccines and medications. Since these have already cleared safety hurdles and are affordable, repurposing them could open doors to more accessible treatments.
To understand how Covid vaccines might intersect with cancer care, let's break down the basics of cancer for beginners. Cancer arises when the body's cells start multiplying uncontrollably instead of following their usual regulated growth patterns. Normally, cell division is tightly managed, but mutations—triggered by factors like smoking, radiation exposure, genetic inheritance, or pollutants—can disrupt this balance. As a result, the immune system struggles to differentiate these rogue 'malignant' cells from healthy ones, allowing them to accumulate into tumors and even spread via new blood vessels, a process known as metastasis. For those new to this, think of it like a garden where weeds (cancer cells) overrun the flowers (healthy cells), and the gardener (immune system) can't tell them apart.
Our immune defenses are stellar at spotting foreign invaders, such as viruses or bacteria, but cancer cells are tricky because they're essentially 'us.' Treatment options vary depending on the situation. For localized tumors, surgery or radiation might suffice to excise or zap the problematic cells. When cancer has metastasized across the body, chemotherapy becomes essential—a harsh method that bombards dividing cells to halt tumor growth, but unfortunately, it also wipes out healthy cells in places like hair roots, stomach linings, and bone marrow, leading to brutal side effects. It's like using a sledgehammer to swat a fly: effective but destructive.
Enter immunotherapy, a smarter alternative that trains the immune system to specifically target cancerous cells. Traditionally, this involves crafting tailored vaccines or drugs for particular cancers, a costly and time-consuming journey through trials for safety, effectiveness, and dosing. Yet, something intriguing seems to occur with mRNA vaccines: rather than zeroing in on a single cancer type, they appear to awaken the immune system broadly, enhancing its ability to combat cancerous cells overall. And this is the part most people miss—these vaccines might act as a universal immune booster, not just a virus fighter.
Delving into the research, a team in the US analyzed records from patients with advanced lung cancer (stages 3 and 4) treated between 2015 and 2022 at the University of Texas MD Anderson Cancer Center. Among them, 180 had received an mRNA Covid vaccine—either Pfizer or Moderna—within 100 days of beginning immunotherapy. This observational analysis compared them to 704 similar patients who underwent the same therapy without the vaccine. After accounting for variables like age and disease progression, the outcomes were eye-opening: vaccinated individuals survived a median of 37.3 months, versus 20.6 months for the unvaccinated. Three years in, 55.7% of vaccinated patients were still alive, compared to just 30.8% of the others. Intriguingly, the benefits held true regardless of whether it was Pfizer or Moderna, but not for non-mRNA Covid vaccines. They even observed similar positive effects in a separate group with metastatic melanoma, a form of skin cancer that's spread widely.
These improvements are nothing short of remarkable, dwarfing the typical gains from new cancer therapies. To put it in perspective, a review of 124 cancer drugs approved by the US FDA from 2003 to 2021 showed that, on average, they only extended median survival by about 2.8 months. So, a 75% boost? That's a potential game-changer for patients.
To unpack this further, scientists conducted experiments on mice, combining mRNA vaccines with immunotherapy. The results? It revved up the immune response, transforming 'cold' tumors—those that evade detection—into visible targets for the body's defenses. What might be driving this? Researchers propose that mRNA vaccines function like a signal flare, rousing immune cells across the body. It's not a direct cancer attack, but a way to heighten overall alertness and responsiveness.
If future studies validate these results, it could transform cancer treatment entirely. As oncologist Dr. Elias Sayour, a co-author of the study, put it: 'We could design an even better non-specific vaccine to mobilise and reset the immune response, in a way that could essentially be a universal, off-the-shelf cancer vaccine for all patients.' Given that Covid mRNA vaccines have been safely administered to millions, there's real promise in using them as a low-cost, low-risk supplement to existing cancer therapies.
Of course, we must temper our excitement with caution. This data stems from an observational study—retrospective medical record reviews, not a controlled experiment designed to test causality. While it shows a strong link, it doesn't prove the vaccine is the cause. Randomized controlled trials (RCTs) are crucial to confirm any direct impact, and more animal research is needed to pinpoint the precise biological pathways, beyond just general immune activation. But here's where it gets controversial: could the lack of RCTs mean we're overlooking a breakthrough, or is it wise to demand rock-solid proof before celebrating? Skeptics might argue that correlation doesn't equal causation, and we shouldn't rush to repurpose vaccines without definitive evidence.
Picture a future with gentler, more precise cancer treatments free from chemotherapy's devastating toll. I recall watching my own father endure grueling chemo cycles, questioning if the treatment was harsher than the illness itself. This Nature study reminds us that scientific leaps often come from unexpected places. The mRNA Covid vaccines, which already shielded lives during the pandemic, might now offer a lifeline against cancer too. Isn't it astonishing how one innovation could ripple into another field?
*
Prof Devi Sridhar is chair of global public health at the University of Edinburgh
*
Fit Forever: Wellness for midlife and beyond. On Wednesday 28 January 2026, join Annie Kelly, Devi Sridhar, Joel Snape and Mariella Frostrup, as they discuss how to enjoy longer and healthier lives, with expert advice and practical tips. Book tickets here or at guardian.live
What do you think—could repurposing Covid vaccines for cancer treatment reshape medicine, or are we getting ahead of ourselves? Do you have personal stories about cancer battles or vaccine experiences? Share your thoughts in the comments below; I'd love to hear differing perspectives!
